130 related articles for article (PubMed ID: 15869020)
1. The role of psychopharmacotherapy in improving the long-term outcome of schizophrenia.
Alam DA; Janicak PG
Essent Psychopharmacol; 2005; 6(3):127-40. PubMed ID: 15869020
[TBL] [Abstract][Full Text] [Related]
2. [Recent advances in clinical psychopharmacology].
Mori A
Yakubutsu Seishin Kodo; 1984 Nov; 4(3):201-12. PubMed ID: 6152505
[TBL] [Abstract][Full Text] [Related]
3. [Drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany].
Vogel M; Köhnlein O; Schmauss M; Messer T
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S173-4. PubMed ID: 15570544
[TBL] [Abstract][Full Text] [Related]
4. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
5. [Influences of second generation antipsychotics on the course of schizophrenia].
Messer T
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S161-3. PubMed ID: 15570540
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.
Kilbourne AM; Post EP; Bauer MS; Zeber JE; Copeland LA; Good CB; Pincus HA
J Affect Disord; 2007 Sep; 102(1-3):145-51. PubMed ID: 17276514
[TBL] [Abstract][Full Text] [Related]
7. [Psychopharmacotherapy in psychiatric nursing homes: myth and reality].
Krüninger U; Herpich S; Schreiber W
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S170-2. PubMed ID: 15570543
[TBL] [Abstract][Full Text] [Related]
8. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
Plesnicar BK; Zalar B; Breskvar K; Dolzan V
J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
[TBL] [Abstract][Full Text] [Related]
9. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
[TBL] [Abstract][Full Text] [Related]
10. Optimisation of long-term treatment in schizophrenia: treating the true spectrum of symptoms.
Kasper S
Eur Neuropsychopharmacol; 2006 Sep; 16 Suppl 3():S135-41. PubMed ID: 16872809
[TBL] [Abstract][Full Text] [Related]
11. [Dilemma of early drug intervention in prepsychotic illnesses of adolescence].
Branik E; Meng H
Prax Kinderpsychol Kinderpsychiatr; 2003 Dec; 52(10):751-65. PubMed ID: 14699785
[TBL] [Abstract][Full Text] [Related]
12. Ethics of the early intervention in the treatment of schizophrenia.
Filaković P; Degmecić D; Koić E; Benić D
Psychiatr Danub; 2007 Sep; 19(3):209-15. PubMed ID: 17914322
[TBL] [Abstract][Full Text] [Related]
13. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of the pharmacologist. From neuroleptics to non-neuroleptic antipsychotics].
Costentin J
Encephale; 2009 Jan; Suppl 3():S119-22. PubMed ID: 19268181
[No Abstract] [Full Text] [Related]
14. [Changes in the clinical picture and course of psychoses as a result of massive psychopharmacotherapy and their role in improving treatment services].
Avrutskiĭ GIa
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(9):1387-94. PubMed ID: 40371
[TBL] [Abstract][Full Text] [Related]
15. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.
Novak Sarotar B; Pesek MB; Agius M; Kocmur M
Neuro Endocrinol Lett; 2008 Dec; 29(6):990-4. PubMed ID: 19112411
[TBL] [Abstract][Full Text] [Related]
16. The relationship between patient satisfaction and treatment outcomes in schizophrenia.
Chue P
J Psychopharmacol; 2006 Nov; 20(6 Suppl):38-56. PubMed ID: 17046986
[TBL] [Abstract][Full Text] [Related]
17. [The first long-acting atypical antipsychotic: new milestone in the treatment of schizophrenia].
Faludi G
Neuropsychopharmacol Hung; 2005 Mar; 7(1):22-7. PubMed ID: 16167464
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic safety and efficacy concerns.
Meyer JM
J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
[TBL] [Abstract][Full Text] [Related]
19. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
20. Weight change with atypical antipsychotics in the treatment of schizophrenia.
Haddad P
J Psychopharmacol; 2005 Nov; 19(6 Suppl):16-27. PubMed ID: 16280334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
